These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 8283521)
1. Bladder permeability in interstitial cystitis is similar to that of normal volunteers: direct measurement by transvesical absorption of 99mtechnetium-diethylenetriaminepentaacetic acid. Chelsky MJ; Rosen SI; Knight LC; Maurer AH; Hanno PM; Ruggieri MR J Urol; 1994 Feb; 151(2):346-9. PubMed ID: 8283521 [TBL] [Abstract][Full Text] [Related]
2. Re: Bladder permeability in interstitial cystitis is similar to that of normal volunteers: direct measurement by transvesical absorption of 99mtechnetium-diethylenetriaminepentaacetic acid. Hohlbrugger G J Urol; 1994 Dec; 152(6 Pt 1):2105-6. PubMed ID: 7966693 [No Abstract] [Full Text] [Related]
3. A Feasibility Study to Determine Whether Clinical Contrast Enhanced Magnetic Resonance Imaging can Detect Increased Bladder Permeability in Patients with Interstitial Cystitis. Towner RA; Wisniewski AB; Wu DH; Van Gordon SB; Smith N; North JC; McElhaney R; Aston CE; Shobeiri SA; Kropp BP; Greenwood-Van Meerveld B; Hurst RE J Urol; 2016 Mar; 195(3):631-8. PubMed ID: 26307161 [TBL] [Abstract][Full Text] [Related]
4. Effect of interstitial cystitis on drug absorption from urinary bladder. Gao X; Buffington CA; Au JL J Pharmacol Exp Ther; 1994 Nov; 271(2):818-23. PubMed ID: 7965801 [TBL] [Abstract][Full Text] [Related]
6. Lack of effect following repeated in vivo exposure of the rabbit urinary bladder to urine from interstitial cystitis patients at low infusion volumes. Kohn IJ; Filer-Maerten S; Whitmore KE; Hanno PM; Ruggieri MR Neurourol Urodyn; 1998; 17(2):147-52. PubMed ID: 9514147 [TBL] [Abstract][Full Text] [Related]
8. A new direct test of bladder permeability. Erickson DR; Herb N; Ordille S; Harmon N; Bhavanandan VP J Urol; 2000 Aug; 164(2):419-22. PubMed ID: 10893600 [TBL] [Abstract][Full Text] [Related]
9. Studies on the permeability of drugs through vesical wall. The fifth report: experiences with intravesical formalin administration. Kawamura N Hinyokika Kiyo; 1983 Oct; 29(10):1279-86. PubMed ID: 6681502 [TBL] [Abstract][Full Text] [Related]
10. Effect of repeated instillation of interstitial cystitis urine on the rabbit urinary bladder. Ruggieri MR; Hanno PM; Whitmore KE; Balagani RK Urology; 1993 Dec; 42(6):646-52. PubMed ID: 8256398 [TBL] [Abstract][Full Text] [Related]
11. Urinary neutrophil chemotactic factors in interstitial cystitis patients and a rabbit model of bladder inflammation. Elgebaly SA; Allam ME; Walzak MP; Oselinsky D; Gillies C; Yamase H J Urol; 1992 May; 147(5):1382-7. PubMed ID: 1569692 [TBL] [Abstract][Full Text] [Related]
12. Interstitial cystitis is associated with intraurothelial Tamm-Horsfall protein. Fowler JE; Lynes WL; Lau JL; Ghosh L; Mounzer A J Urol; 1988 Dec; 140(6):1385-9. PubMed ID: 3193502 [TBL] [Abstract][Full Text] [Related]
13. [Studies on the drug permeability of vesical walls. The permeability of mecillinam from the bladder]. Kawamura N; Okada K; Kinoshita H; Sameshima M; Matsunaga J; Kawakami T; Hashimoto T Jpn J Antibiot; 1987 Apr; 40(4):739-42. PubMed ID: 3613090 [TBL] [Abstract][Full Text] [Related]
14. Intravesical hyaluronic acid for interstitial cystitis/painful bladder syndrome: a comparative randomized assessment of different regimens. Lai MC; Kuo YC; Kuo HC Int J Urol; 2013 Feb; 20(2):203-7. PubMed ID: 22925498 [TBL] [Abstract][Full Text] [Related]
15. Elevated nitric oxide in the urinary bladder in infectious and noninfectious cystitis. Lundberg JO; Ehrén I; Jansson O; Adolfsson J; Lundberg JM; Weitzberg E; Alving K; Wiklund NP Urology; 1996 Nov; 48(5):700-2. PubMed ID: 8911512 [TBL] [Abstract][Full Text] [Related]
16. Permeability characteristics of the rat urinary bladder in experimental cystitis and after overdistension. Hohlbrugger G; Lentsch P; Pfaller K; Madersbacher H Urol Int; 1985; 40(4):211-6. PubMed ID: 3901473 [TBL] [Abstract][Full Text] [Related]
17. Preclinical Animal Studies of Intravesical Recombinant Human Proteoglycan 4 as a Novel Potential Therapy for Diseases Resulting From Increased Bladder Permeability. Greenwood-Van Meerveld B; Mohammadi E; Latorre R; Truitt ER; Jay GD; Sullivan BD; Schmidt TA; Smith N; Saunders D; Ziegler J; Lerner M; Hurst R; Towner RA Urology; 2018 Jun; 116():230.e1-230.e7. PubMed ID: 29545038 [TBL] [Abstract][Full Text] [Related]
18. Adriamycin permeability of the rat bladder under different conditions. Engelmann U; Bürger RA; Rumpelt JH; Jacobi GH J Urol; 1983 Apr; 129(4):862-4. PubMed ID: 6842726 [TBL] [Abstract][Full Text] [Related]
19. Decreased expression of a glycoprotein component of bladder surface mucin (GP1) in interstitial cystitis. Moskowitz MO; Byrne DS; Callahan HJ; Parsons CL; Valderrama E; Moldwin RM J Urol; 1994 Feb; 151(2):343-5. PubMed ID: 8283520 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of prostaglandin E2 and E-series prostaglandin receptor in patients with interstitial cystitis. Wada N; Ameda K; Furuno T; Okada H; Date I; Kakizaki H J Urol; 2015 Jun; 193(6):1987-93. PubMed ID: 25595860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]